Corvus Pharmaceuticals Inc (CRVS)
8.94
+0.70
(+8.50%)
USD |
NASDAQ |
Nov 21, 16:00
8.90
-0.04
(-0.45%)
After-Hours: 20:00
Corvus Pharmaceuticals Max Drawdown (5Y): 95.82% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 95.82% |
| September 30, 2024 | 95.82% |
| August 31, 2024 | 95.82% |
| July 31, 2024 | 95.82% |
| June 30, 2024 | 95.82% |
| May 31, 2024 | 95.82% |
| April 30, 2024 | 95.82% |
| March 31, 2024 | 95.82% |
| February 29, 2024 | 95.82% |
| January 31, 2024 | 95.82% |
| December 31, 2023 | 95.82% |
| November 30, 2023 | 95.82% |
| October 31, 2023 | 95.82% |
| September 30, 2023 | 95.82% |
| August 31, 2023 | 95.82% |
| July 31, 2023 | 95.82% |
| June 30, 2023 | 95.82% |
| May 31, 2023 | 95.82% |
| April 30, 2023 | 95.82% |
| March 31, 2023 | 95.82% |
| February 28, 2023 | 95.82% |
| January 31, 2023 | 95.82% |
| December 31, 2022 | 95.82% |
| November 30, 2022 | 95.82% |
| October 31, 2022 | 95.82% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.82% |
| August 31, 2022 | 95.00% |
| July 31, 2022 | 94.95% |
| June 30, 2022 | 94.95% |
| May 31, 2022 | 94.39% |
| April 30, 2022 | 93.17% |
| March 31, 2022 | 93.17% |
| February 28, 2022 | 92.42% |
| January 31, 2022 | 92.42% |
| December 31, 2021 | 91.86% |
| November 30, 2021 | 91.86% |
| October 31, 2021 | 91.86% |
| September 30, 2021 | 91.86% |
| August 31, 2021 | 91.86% |
| July 31, 2021 | 91.86% |
| June 30, 2021 | 91.86% |
| May 31, 2021 | 91.86% |
| April 30, 2021 | 91.86% |
| March 31, 2021 | 91.86% |
| February 28, 2021 | 91.86% |
| January 31, 2021 | 91.86% |
| December 31, 2020 | 91.86% |
| November 30, 2020 | 91.86% |
| October 31, 2020 | 91.86% |
| September 30, 2020 | 91.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.02%
Minimum
Nov 2019
95.82%
Maximum
Sep 2022
93.58%
Average
93.78%
Median
Max Drawdown (5Y) Benchmarks
| Azenta Inc | 70.61% |
| Perspective Therapeutics Inc | 91.70% |
| Atara Biotherapeutics Inc | 99.47% |
| Clearside Biomedical Inc | 95.91% |
| Quanterix Corp | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 5.666 |
| Beta (5Y) | 1.048 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 141.8% |
| Historical Sharpe Ratio (5Y) | 0.1354 |
| Historical Sortino (5Y) | 0.4941 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.84% |